All posts tagged "CytoDyn Inc."

• 

  1.2K

  Biotech

  CytoDyn Doubles Down on Revenue and EUA Strategy with Philippines Announcement

  CytoDyn Inc. (OTCMKTS: CYDY) announced yesterday that it shipped 28 doses of leronlimab under Compassionate Special Permit (CSP) to one hospital in...

• 

  1.2K

  Biotech

  COVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data

  Humanigen Inc. (NASDAQ: HGEN) released excellent news that their drug lenzilumab improved survival without the need for invasive mechanical ventilation (IMV) by...

• 

  2.3K

  3

  Biotech

  CytoDyn Saves Lives & Reduces COVID-19 Hospital Duration

  6 endpoints met after full data release so shorts double down on trial failure narrative  Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...

• 

  17.7K

  1

  Biotech

  Reddit Rebellion Targeting The Short Mafia Next

  The BANG stocks (Blackberry (NYSE: BB), AMC Entertainment (NYSE: AMC), Nokia Inc. (NYSE: NOK), GameStop Corp (NYSE: GME) are experiencing wild price...

• 

  12.7K

  Biotech

  RISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)

  Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NASDAQ Uplisting for...

• 

  12.7K

  1

  Biotech

  CytoDyn (OTCMKTS: CYDY) Subtly Signals Pivot Into Philippines and Vaccine Market

  On Sunday Night CytoDyn Inc. (OTCMKTS:CYDY) quietly placed a link in their developing news section to a 2016 medical journal article that...

• 

  5.9K

  1

  Biotech

  CytoDyn (OTCMKTS: CYDY) Accelerates Recruitment to 250 Patients in Pivotal COVID-19 Trial

  CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to critical...

• 

  10.9K

  Biotech

  Handicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout

  Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken  A...

• 

  30.2K

  1

  Biotech

  CytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval

  CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today.  The company reported a...

• 

  26.4K

  Biotech

  UK Prime Minister Boris Johnson Linkage to CytoDyn (OTCMKTS: CYDY) Evolving

  CytoDyn Inc. (OTCMKTS: CYDY) announced today it was collaborating with the United Kingdom’s Department of Health to provide emergency access to leronlimab...